BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15837986)

  • 1. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
    Olivotto IA; Bajdik CD; Ravdin PM; Speers CH; Coldman AJ; Norris BD; Davis GJ; Chia SK; Gelmon KA
    J Clin Oncol; 2005 Apr; 23(12):2716-25. PubMed ID: 15837986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies.
    Chia SK; Speers CH; Bryce CJ; Hayes MM; Olivotto IA
    J Clin Oncol; 2004 May; 22(9):1630-7. PubMed ID: 15117985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
    Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model.
    Ozanne EM; Braithwaite D; Sepucha K; Moore D; Esserman L; Belkora J
    J Clin Oncol; 2009 Jan; 27(2):214-9. PubMed ID: 19047286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in node negative premenopausal women treated with breast conserving therapy without adjuvant systemic therapy.
    Budrukkar AN; Sarin R; Chinoy RF; Badwe R; Shrivastava SK; Dinshaw KA
    Breast; 2008 Jun; 17(3):263-9. PubMed ID: 18060781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer.
    Truong PT; Bernstein V; Lesperance M; Speers CH; Olivotto IA
    Am J Surg; 2006 Jun; 191(6):749-55. PubMed ID: 16720143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
    Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy.
    Truong PT; Lee J; Kader HA; Speers CH; Olivotto IA
    Eur J Cancer; 2005 Jun; 41(9):1267-77. PubMed ID: 15939262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?
    Goodwin PJ; Ennis M; Fantus IG; Pritchard KI; Trudeau ME; Koo J; Hood N
    J Clin Oncol; 2005 Sep; 23(25):6037-42. PubMed ID: 16135472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
    Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
    J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.
    Lohrisch C; Paltiel C; Gelmon K; Speers C; Taylor S; Barnett J; Olivotto IA
    J Clin Oncol; 2006 Oct; 24(30):4888-94. PubMed ID: 17015884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
    J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
    Olivotto IA; Lesperance ML; Truong PT; Nichol A; Berrang T; Tyldesley S; Germain F; Speers C; Wai E; Holloway C; Kwan W; Kennecke H
    J Clin Oncol; 2009 Jan; 27(1):16-23. PubMed ID: 19018080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiosarcoma of the breast.
    Vorburger SA; Xing Y; Hunt KK; Lakin GE; Benjamin RS; Feig BW; Pisters PW; Ballo MT; Chen L; Trent J; Burgess M; Patel S; Pollock RE; Cormier JN
    Cancer; 2005 Dec; 104(12):2682-8. PubMed ID: 16288486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.